Cystic Fibrosis Screen – General screen for carrier status and assessment of CF risk. This test will identify approximately 90% of Cystic Fibrosis (CF) mutations in the Caucasian population, and 97% in the Ashkenazi Jewish population. Synonyms: CF Mutation Screen, Cystic Fibrosis Mutation Screen, CFTR Screen, CF Carrier Screen, CF Screen, Cystic Fibrosis Carrier Screen
4 mL whole blood collected in an EDTA (lavender-top) tube. Stability: Room temperature – 8 days, Refrigerated: 8 days, Frozen – Unacceptable.